Evidence map›Paper›PMID 26617965›Full record

ArticleACS medicinal chemistry letters2015

Borrelidin Induces the Unfolded Protein Response in Oral Cancer Cells and Chop-Dependent Apoptosis.

Alpa Sidhu, Justin R Miller, Ashootosh Tripathi, Danielle M Garshott, Amy L Brownell, Daniel J Chiego, Carl Arevang, Qinghua Zeng, Leah C Jackson, Shelby A Bechler and 9 more

Open access · greenAbstract read
In one paragraph

Article in ACS medicinal chemistry letters, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Impact and Relevance of the Unfolded Protein Response in HNSCC.International journal of molecular sciences · 2019
    Review
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Review
  16. Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 6 institutions in 2 countries.

Alpa SidhuCarmen and Ann Adams Department of Pediatrics, Wayne State University School of Medicine , Detroit, Michigan 48201, United States.
Justin R MillerCarmen and Ann Adams Department of Pediatrics, Wayne State University School of Medicine , Detroit, Michigan 48201, United States.
Ashootosh TripathiLife Sciences Institute and Departments of Medicinal Chemistry, Chemistry, Microbiology & Immunology, University of Michigan , Ann Arbor, Michigan 48109, United States.
Danielle M GarshottCarmen and Ann Adams Department of Pediatrics, Wayne State University School of Medicine , Detroit, Michigan 48201, United States.
Amy L BrownellCarmen and Ann Adams Department of Pediatrics, Wayne State University School of Medicine , Detroit, Michigan 48201, United States.
Daniel J ChiegoCariology, Restorative Sciences and Endodontics, University of Michigan School of Dentistry , Ann Arbor, Michigan 48109, United States.
Carl ArevangLife Sciences Institute and Departments of Medicinal Chemistry, Chemistry, Microbiology & Immunology, University of Michigan , Ann Arbor, Michigan 48109, United States.
Qinghua ZengCarmen and Ann Adams Department of Pediatrics, Wayne State University School of Medicine , Detroit, Michigan 48201, United States.
Leah C JacksonCarmen and Ann Adams Department of Pediatrics, Wayne State University School of Medicine , Detroit, Michigan 48201, United States.
Shelby A BechlerCarmen and Ann Adams Department of Pediatrics, Wayne State University School of Medicine , Detroit, Michigan 48201, United States.
Michael U CallaghanCarmen and Ann Adams Department of Pediatrics, Wayne State University School of Medicine , Detroit, Michigan 48201, United States.
George H YooDepartment of Otolaryngology, Wayne State University and Karmanos Cancer Institute , Detroit, Michigan 48201, United States.
Seema SethiDepartment of Pathology, Wayne State University and Karmanos Cancer Institute , Detroit, Michigan 48201, United States.
Ho-Sheng LinDepartment of Otolaryngology, Wayne State University and Karmanos Cancer Institute , Detroit, Michigan 48201, United States.
Joseph H CallaghanSchool of Business Administration, Oakland University , Rochester, Michigan 48309, United States.
Giselle Tamayo-CastilloInstituto Nacional de Biodiversidad, CIPRONA-Escuela de Química, Universidad de Costa Rica , 3100 Heredia, Costa Rica.
David H ShermanLife Sciences Institute and Departments of Medicinal Chemistry, Chemistry, Microbiology & Immunology, University of Michigan , Ann Arbor, Michigan 48109, United States.
Randal J KaufmanDegenerative Disease Research Program, Center for Cancer Research, Sanford|Burnham Medical Research Institute , La Jolla, California 92037, United States.
Andrew M FribleyCarmen and Ann Adams Department of Pediatrics, Wayne State University School of Medicine , Detroit, Michigan 48201, United States ; Department of Otolaryngology, Wayne State University and Karmanos Cancer Institute , Detroit, Michigan 48201, United States ; Developmental Therapeutics Program, Barbara Ann Karmanos Cancer Institute , Detroit, Michigan 48201, United States.
Wayne State University · USUniversity of Michigan–Ann Arbor · USOakland University · USSanford Burnham Prebys Medical Discovery Institute · USThe Barbara Ann Karmanos Cancer Institute · USUniversidad Nacional · CR

Funding

Tumor Microenvironment and Cancer ImmunologyP30CA030199 · NCI · SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · PI ELENA B PASQUALE · 1985 to 2026
$107.2M
NCI NIH HHS P30 CA030199
6 · The paper itself

Abstract

Oral squamous cell carcinoma (OSCC) is the most common cancer affecting the oral cavity, and US clinics will register about 30,000 new patients in 2015. Current treatment modalities include chemotherapy, surgery, and radiotherapy, which often result in astonishing disfigurement. Cancers of the head and neck display enhanced levels of glucose-regulated proteins and translation initiation factors associated with endoplasmic reticulum (ER) stress and the unfolded protein response (UPR). Previous work demonstrated that chemically enforced UPR could overwhelm these adaptive features and selectively kill malignant cells. The threonyl-tRNA synthetase (ThRS) inhibitor borrelidin and two congeners were discovered in a cell-based chemical genomic screen. Borrelidin increased XBP1 splicing and led to accumulation of phosphorylated eIF2α and UPR-associated genes, prior to death in panel of OSCC cells. Murine embryonic fibroblasts (MEFs) null for GCN2 and PERK were less able to accumulate UPR markers and were resistant to borrelidin. This study demonstrates that UPR induction is a feature of ThRS inhibition and adds to a growing body of literature suggesting ThRS inhibitors might selectively target cancer cells.

Indexed as

borrelidinChopER stresshigh throughput screennatural productsoral canceroral squamous cell carcinomaprotein foldingUPRXbp1, BiP/GRP78

Identifiers

PMID26617965
PMCPMC4645248
OpenAlexW2201636020

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.